Research reading
Medicaments: containing antimalarial active principles described in Subheading Note 2 to this Chapter, for therapeutic or prophylactic uses, packaged for retail sale demand and the South Korea (KOR) to Eritrea (ERI) lane
Eritrea (ERI) reported $36.5K of medicaments: containing antimalarial active principles described in subheading note 2 to this chapter, for therapeutic or prophylactic uses, packaged for retail sale imports in 2009. South Korea (KOR) accounted for 0.2% of the observed market and reported $120.2 in exports on this lane.
The latest annual values eased slightly, while the longer available history shows +14.9% buyer growth and -20% exporter growth. The page separates reported values from projections and indicators.
